Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history shows a new revision, v3.3.2, replacing the prior v3.3.1, indicating a metadata update rather than a change to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe history page shows a new site revision from v3.2.0 to v3.3.1 in the footer. This is a minor maintenance update and does not affect study information or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the government funding/operating status banner from the page header.SummaryDifference0.4%

- Check43 days agoChange DetectedThe new screenshot shows a revised layout and styling for the Record History page, with the same version history entries and study data as before. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference9%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.